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In a  preceding communication (1)  it was shown that antipneumo- 
coccic serum contains, in addition to the antibodies against the various 
bacterial  constituents,  a  so  called  non-antibacterial  factor  which 
apparently is capable of playing an important r61e in pneumococcus 
infection.  The  therapeutic effectiveness of  this  factor was  demon- 
strated on the experimental, dermal pneumococcus infection of rabbits 
in serum from which the antibacterial bodies were removed by absorp- 
tion  with  the homologous,  virulent,  heat-killed pneumococci.  The 
immunological nature and the mode of action of the non-antibacterial 
factor are still obscure. 
Since fractionation of antipneumococcic serum by various methods 
showed that almost all of its mouse protective potency was associated 
with the water-insoluble globulin, refined preparations, which are at 
present used and recommended by many for the treatment of certain 
types of pneumococcus pneumonia in man, contain this fraction only. 
On the other hand, it is known that diphtheria and tetanus antitoxin, 
for example, are for the most part associated with the water-soluble 
globulin,  and  that  in  the  refined and  concentrated preparations  of 
antiscarlatinal  serum,  both  the  water-soluble  and  water-insoluble 
globulins  are included.  The purpose of the investigations reported 
in this communication was first, to determine the distribution of the 
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non-antibacterial  factor of antipneumococcic serum among its various 
protein fractions, partly as an aid in establishing its nature by correla- 
tion with the distribution of the known immune bodies; and second, to 
observe  and  compare  the  effect of the  different  fractions  and  of the 
whole  serum  on  the  experimental  dermal  pneumococcus infection in 
rabbits. 
EXPERIMENTAL 
The details and procedures of the dermal pneumococcus infection as used in 
these experiments, were described in the first communication.  The same virulent 
strain  of Type I  Pneumococcus was employed and  the same qualifications and 
acknowledgments obtain here.  Two additional  problems  presented  themselves 
in  the  following  experiments:  One  dealt  with  the  manner  of  determining  the 
concentration of the non-antibacterial factor, and the other with a  suitable and 
reliable method of titrating the therapeutic effectiveness of a preparation. 
Although it was previously shown that a certain number of rabbits are protected 
when treated with the non-antibacterial factor alone, this effect could not be used 
as a criterion on account of its obvious irregularity.  The complementary effect of 
this factor when administered with a certain, constant, definitely subeffective dose 
of serum,  appeared  to be the more suitable,  available  criterion.  Although the 
virulence of the culture was such that with the number of organisms injected none 
of the untreated rabbits survived,  the resistance of different rabbits appears to 
vary to such an extent that some when treated are protected by a dose which is 
ineffective for most, whereas certain others are not protected by a  dose effective 
for most.  The term subeffective is used to designate a  dose which contains an 
adequate amount of antibacterial bodies, expressed in units of mouse protective 
antibody, but an insufficient concentration of the non-antibacteriaI factor, with 
the result that the majority of rabbits do not survive.  The standard subeffective 
dose selected  for this  work contained  300 mouse protective units  in  0.3  cc.  of 
serum, and of various groups of rabbits treated with this dose 60 to 80 per cent 
died as instanced by the fact that of groups of five rabbits tested with this dose on 
various occasions, three always died and sometimes four.  For titrating the con- 
centration of the non-antibacterial factor, varying amounts of the absorbed prepa- 
rations were injected along with the subeffective dose; a survival of at least three 
of five rabbits was required to indicate an effect of the added substance.  It is 
realized that an absorbed serum or preparation does not necessarily contain all of 
the non-antibacterial  factor that  may be present  in the original, for during the 
process of precipitation and agglutination some may conceivably be carried down 
and removed with the organisms.  However, by employing the same method on 
all the preparations, the relative values may, nevertheless, be comparable. 
For the determination of a minimal effective dose of a serum, Goodner (2) used 
a single rabbit for each dose, and certain criteria with regard to temperature, lesion, ALBERT  B.  SABIN  141 
and bacteremla to determine its efficacy.  In the course of the present work, it was 
observed, however, that many rabbits which do not fulfill those criteria in the 
specified  time or manner, nevertheless survive.  If rabbits of uniform suscepti- 
bility or resistance could be gotten, it is not improbable that results obtained with 
single rabbits might be reproducible; but among the rabbits which were available 
for these experiments such uniformity did not obtain.  To overcome largely this 
variation in resistance, groups of five rabbits were used for each dose; and for a 
dose to be considered  effective at least three of the five rabbits had to survive for 
10  days. 
Distribution of the Non-Antibacterial Factor among the Protein Fractions 
o/Antilmeumococdc  Serum 
In the fractionation of horse antipneumococcic serum with  (NI-I,)i- 
SO,, Banzhaf  (3)  showed that the protein precipitated at 30 per cent 
saturation,  contained  relatively  little  mouse  protective  antibody 
(approximately 10 per cent of the total), whereas that which is precipi- 
tated when the concentration of (NH,)2SO4 is increased to 50 per cent 
saturation  contains  all  the  rest;  and  in  agreement  with  Felton's  (4) 
observations, he  further  showed  that  the  mouse protective antibody 
in the latter fraction (i.e. 30 --~ 50 per cent saturation with (NH,)2SO,) 
was associated with its water-insoluble protein.  It is essential to recall 
here that in the fractionation of antitoxic sera, most of the antitoxin 
is found with the water-soluble portion of the same globulin. 
With  these facts in mind,  the  distribution  of the  non-antibacterial 
factor was studied in two monovalent, Type I  antipneumococcic sera. 
The following fractions of Serum 54 were isolated for testing:  (a) that precipi- 
tated at 30 per cent saturation with (NH4)2SO4, and which,  for convenience, will 
henceforth  be called  30  per cent  (NI-I,)2SO, globulin;  (b)  that  precipitated  by 
increasing the concentration of (NH4)2SO, to 50 per cent saturation, and to be called 
the 30 --~ 50 per cent (NH4)2SO4 globulin;  this fraction was further subdivided into 
water-soluble (soluble at a N/100 NaCI concentration) and water-insoluble  (insolu- 
ble at N/100  NaC1) portions; (c) that precipitated by increasing  the  (NH4)2SO, 
concentration from 50 per cent to complete saturation; this fraction is commonly 
called  albumen.  (The (a)  and  (b)  fractions were deliberately not designated  as 
euglobulin and pseudoglobulin,  because these terms, in their present state of defini- 
tion as regards serum proteins, convey neither the same meaning nor the  same 
constitution to all people.)  The acid fraction q.e. insoluble  at pH 5.0  and  N/20 
salt concentration) was removed from the 30 ~  50 per cent (NI-I4)2SO,  globulin. 
Felton (5) first observed that this acid fraction contained very little antibody, and 
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of "chills and hyperpyrexia" was decreased; Sabin and Wallace (6) in a controlled, 
experimental study on the nature of the chill-producing principle,  confirmed this 
observation and showed that the chill-producing principle is actually associated to 
a much greater extent with this acid fraction than with any of the other protein 
fractions.  After isolation,  the various globulin fractions of Serum 54 were dis- 
solved each in one-tenth the volume of serum from which they were derived; i.e., 
they were concentrated ten times by volume. 
In testing for the content of non-antibacterial factor, all the fractions,  except 
the albumen,  were completely absorbed  with concentrated suspensions of heat- 
killed, virulent, Type I  pneumococci;  the albumen had no demonstrable  agglu- 
tinins.  Varying amounts of each absorbed fraction and of the absorbed original 
serum were administered intravenously along with the standard subeffective dose 
(0.3 cc. of Serum 624), 6 hours after the intracutaneous injection of the culture; 
as a rule, five rabbits were injected with each dose.  On account of the large num- 
ber of rabbits required for such a test, the titration is not as fine as might be desired. 
The data presented in Table I  were obtained in four separate tests. 
2.0  cc. of absorbed Serum 54 contained sufficient of the non-antibac- 
terial factor to produce a  typical effect in conjunction with the sub- 
effective dose.  An equivalent dose of 10.0 cc. of the absorbed water- 
soluble as well as water-insoluble  fractions of the 30 -~  50 per cent 
(NH~)2SO4  globulin was necessary to produce an effect similar to that 
exerted by 2.0  cc.  of the  original  serum.  With  equivalent  doses of 
5.0 cc. of the 30 per cent (NH~)2SO4  globulin and 4.0 cc. of albumin, 
doubtful effeqts were exerted; it is not improbable that larger doses 
would  have  been  effective.  Thus  the  results  obtained  with  the 
various protein fractions suggest  that  the non-antibacterial factor is 
probably  distributed  among  all  of  them;  particularly  significant, 
however, is the fact that there does not appear to be any difference 
between the quantity present in the water-soluble and water-insoluble 
fractions.  The concentration of the factor in each individual fraction 
is,  relatively, considerably  less  than in  the  original.  Although  the 
association of the factor with all the protein fractions would necessarily 
reduce its effective concentration in each one, it does not completely 
explain the extent of the observed diminution. 
In absorbed Serum 348, the activity of the non-antibacterial factor 
is well demonstrated, 0.5 cc. of it being an effective dose.  Three frac- 
tions of Serum 348 were tested; (1)  The total globulin precipitated by 
50 per cent saturation with (NH4)~SO4,  (2)  the 30 per cent (NH4)~SO4 TABLE  I 
Distribution of Non-Antibacterial Factor among Protein Fractions of Antipneumo- 
cocclc Serum 
Fraction added to subeffective dose-- 
0.3 cc. Serum 624 
Absorbed Serum 54 
Absorbed  30 per  cent  (NH4)2- 
SO4 Globulin 54 
Absorbed water-insoluble 30 -* 
50 per cent (NIff4),SO4 Glob- 
ulin 54 
~bsorbed  water-soluble 30  --* 
50 per cent (NI-I,)2SO4 Glob- 
ulin 54 
Dose 
CC. 
2.0 
0.5 
0.3 
1.0 
0.3 
0.75 
1.0 
Equivalent 
to volume of 
whole serum 
2.0 
5.0 
3.0 
10.0 
3.0 
7.5 
10.0 
Effect on rabbits 
S 
S 
S 
S 
D~ 
Do? 
S 
S 
D6 
D6 
S 
D6 
D6 
D>ID  >1} excluded 
S 
S 
S 
S 
Ds? 
S 
D4 
D6 
De 
D8 
S 
S 
D6 
D6 
S 
S 
S 
Ds? 
D6 
Action of added 
non-antlbacte- 
rial factor 
Positive 
Doubtful 
Negative 
Positive 
Negative 
Doubtful 
Positive 
S  =  survived.  D4  =  dead on 4th day. 
not being due to pneumococcus infection. 
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TABLE  I--Continued 
Fraction added to subeffective  dose--  Equivalent  Action of added 
0.3 cc. Serum 624  Dose  to volume  of  Effect  on rabbits  non-antibacte- 
whole serum  rial factor 
CG.  C~. 
Albumin of Serum 54  4.0  4.0  Doubtful 
0.2  0.2 
S 
S 
D6 
D7 
Absorbed Serum348 
Absorbed 50 per cent (NH0,SO4 
total Globulin 348 
Absorbed 30 per cent (NI-I02SO, 
Globulin 348 
0.5 
1.0 
0.5 
1.0 
1.0 
0.5 
1.0 
0.5 
1.0 
1.0 
S 
S 
Dz 
D~ 
Dlo 
S 
S 
S 
D11? 
D3 
S 
S 
D. 
D5 
D7 
S 
D8 
Ds 
D7 
D1o 
S 
D8 
D5 
D7 
D10 
Negative 
Positive 
Positive 
Negative 
Negative 
Negative ALBERT  B.  SABIN 
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Fraction added to subettectlve dose-- 
0.3 cc. Serum 624 
Absorbed Serum 348 
Absorbed 50 per cent (NI-I~)2SO4 
total Globulin 348 
Albumin of No. 348 
None 
Dose 
G¢. 
0.5 
2.5 
1.0 
5.0 
Equivalent 
to volume of 
whole serum 
0.5 
2.5 
1.0 
5.0 
Edtact on rabbits 
S 
S 
S 
S 
Ds 
S 
S 
S 
S 
D7 
S 
S 
S 
D, 
Db 
S 
S 
S 
D7 
D9 
S 
S 
S 
D~ 
D6 
D6 
De 
D~ 
D9 
D10 
Action of added 
non-antibacte- 
rlal factor 
Positive 
Positive 
Positive 
Positive 
globulin,  and  (3)  the  albumen.  The fractions were dissolved in  the 
same volume of 1 per cent NaC1 as that of the serum from which they 
were derived.  Of the total globulin, which represented approximately 
65 per cent of the total protein nitrogen of the serum, twice the mini- 
mal effective dose of the original serum failed to produce the  typical 146  ACTION  OF  ANTIPNEUMOCOCCIC  SERUM.  II 
effect of the non-antibacterial factor, whereas five times that dose did. 
The  albumen  which  was  added  without  preliminary  absorption 
(because it contained no agglutinins) also increased the effectiveness of 
the subeffective dose.  However, the method used for determining the 
concentration of the non-antibacterial factor is probably inadequate; 
the chief source of probable error may perhaps be associated with the 
necessary  absorption  procedure,  which  may  conceivably  remove 
certain, varying amounts of the factor in the precipitate which forms 
on the bacteria.  For this  reason the results of this experiment are 
regarded primarily from a qualitative point of view; as such they show 
the association of the non-antibacterial factor with protein fractions 
which contain little or none of the mouse protective antibody.  This 
distribution of the factor in no way corresponds to that of the known 
antitoxins. 
The  Relationship  between the  Antibacterial  and  Non-Antibacterial 
Factors in the  Therapeutic  Effect  Exerted  by  Whole Antipneumo- 
coccic Serum  and  Some  of  Its  Globulin  Fractions 
The results of the preceding experiment showed that the non-anti- 
bacterial factor apparently is associated with almost all  the protein 
fractions of the serum, and with the method used for its determination 
it appeared as though there might be no marked difference in its quanti- 
tative  distribution.  Since,  however,  approximately 90  per  cent  of 
the antibacterial bodies are associated with the water-insoluble fraction 
of the 30  --~ 50  per cent  (NH,)2SO4  globulin,  the ratio of  the anti- 
bacterial to the non-antibacterial factor would be expected to vary in 
the different fractions.  Thus if the therapeutic effect of a given dose 
were to depend primarily upon its content of antibacterial bodies, one 
would expect the amounts of the different fractions required for a 
minimal effective dose (~.E.D.)  to be roughly proportional to the num- 
ber of mouse protective units; on the other hand, if the therapeutic 
effect depended largely on the non-antibacterial factor, the amounts 
required for 1 ~.E.D. should be approximately the same for the different 
fractions. 
The monovalent, Type I  Serum 54 and the globulin fractions used 
in the preceding experiment were tested for their content of mouse ALBERT  B.  SABIN  147 
protective  antibody  and  for  the  minimal  dose  effective against  the 
experimental,  dermal  pneumococcus infection in  rabbits. 
In the mouse protection test at least 5 to 10 mice were used for each dose and the 
unit represents ten times the smallest  amount of serum required to  protect a 
majority of the mice for at least 96 hours, the serum being injected intraperitoneally 
simultaneously  with 100,000 M.L.D.'S of a fully virulent culture.  In determining 
the minimal effective dose (~r.E.D.) on rabbits, the serum was administered intrave- 
nously 6 to 7 hours after the intracutaneous injection of the organisms.  Although 
the severity of the lesions, and the course of the temperature and bacteremia were 
observed, they served merely as a qualitative index, the final criterion of effective- 
ness being a survival of a majority of the rabbits for at least 10 days.  When only 
three rabbits were used for each dose, as in a preliminary test, all three had to 
survive; with five rabbits per dose, the survival of at least three also constituted 
the result of an effective dose. 
The  data  are  presented  in  Table  II.  The ~r.E.D. of  the original 
serum  was  approximately  0.6  cc.,  this  dose  containing  600,  <  900 
m. p. u.  (mouse protective units).  The ~.E.D. of the water-insoluble 
fraction of the 30 --. 50 per cent (NH,)~SO, globulin was not more than 
0.2 cc., containing 800,  <  2,000 m. p. u.; the M.E.D. of the water-soluble 
fraction of the same globulin was 1.0 cc., containing 40,  <  60 m. p. u. ; 
and the ~.E.D. of the 30 per cent (NH4),SO~ globulin was approximately 
0.25 cc., containing 200,  <  300 m. p.u.  In  comparing the doses of 
the original serum with those of the globulin fractions,  it should be 
recalled that the latter were dissolved in one-tenth the original volume. 
An analysis of the data reveals that the amounts required for 1 M.E.D., 
as well as the m. p. u. content of 1 M.E.D., vary markedly for the differ- 
ent globulin fractions and the original  serum.  These differences are 
striking, even if one shotfld allow 100 per cent experimental variation, 
and are best observed between the water-soluble and water-insoluble 
fractions of the 30  --~ 50 per cent  (NH4)2SO4  globulin.  200,  <  500 
m. p. u. in 0.05 cc. of the water-insoluble fraction is definitely ineffec- 
tive, whereas 40,  <  60 m. p.  u. in 1.0 cc. of the water-soluble fraction 
is  fully effective.  Similarly  1  M.E.D. of  the  30  per  cent  (NI-I4),SO4 
globulin has  am.  p.  u.  content which  is in  the  ineffective range  of 
both the water-insoluble globulin and the original serum.  It is  thus 
quite obvious that even in a  comparison of  antipneumococcic serum 
and the protein fractions derived from it, the therapeutic effectiveness 148  ACTION  OF  ANTIPNEUMOCOCCIC  SERUM.  II 
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does not depend solely upon the concentration of mouse  protective 
antibody, an observation which is fully in agreement with those made 
in  the  first  communication.  When  the  volumes  and  the  m.  p. u. 
content of 1 M.~-.D. are correlated, one  finds that the lower m. p.  u. 
values are associated with almost proportionately higher volumes, and 
vice versa.  Of the globulin fractions, which contain relatively little 
mouse  protective  antibody,  like  the  water-soluble  or  30  per cent 
(NH4)~SO4, the volume of 1 ~.E.D.  is greater than that of the water- 
insoluble protein but the m. p. u. content, instead of being about the 
same, is almost proportionately less.  It can be stated: therefore, that 
when a  given dose contains a  relatively large amount of one factor 
(antibacterial or non-antibacterial), a relatively smaller amount of the 
other is required and vice versa.  Thus,  the therapeutic effectiveness 
of antipneumococcic serum or its protein fractions is found to depend 
not upon the absolute concentration of either the antibacterial or the 
non-antibacterial bodies, but upon the relative concentration of the 
two, an abundance of one apparently making up for the scarcity of the 
other. 
Effect of Whole Antipneumococcic Serum and of Various of Its  Protein 
Fractions on the Experimental Dermal Pneumococcus 
Infection in Rabbits 
In the treatment of Types I  and II pneumococcus pneumonia in 
man, the use of refined and concentrated preparations of antipneumo- 
coccic serum has been quite generally accepted, although Cole (7) of 
the Hospital of The Rockefeller Institute for Medical Research still 
advocates the use of whole unrefined serum for various reasons which 
he has set down.  Chief among the methods of refining and concen- 
trating antipneumococcic serum are those of Felton and of Banzhaf. 
Whichever of Felton's methods is used, the final preparation contains 
only the water-insoluble  globulin.  Banzhaf (3)  early  attempted  to 
achieve further purification by excluding also the globulin precipitated 
by 30 per cent saturation with (NI-Ia)2SO4 or by 12.5 per cent Na~SO4. 
The exclusion of this fraction by Banzhaf and of the albumen and total 
water-soluble globulin  in  all  the other methods,  is  based  upon  the 
observation that these fractions contain very little or none of the so 
called protective antibody as determined by the mouse protection test. 152  ACTION  OF  ANTIPNEUMOCOCCIC  SERUM.  II 
In the preceding communication, as well as in the preceding experi- 
ments  of  the  present  communication,  it  has  been  shown  that  the 
therapeutic action of antipneumococcic serum is dependent not only 
upon this mouse protective antibody but also upon other factors which 
are apparently non-antibacterial.  This consideration brings up  cer- 
tain  questions which have a  direct  bearing  upon  the  nature of  the 
preparations  to  be used in the therapy of pneumococcus pneumonia 
in  man.  One  question,  naturally, is  whether by  excluding  all  the 
proteins, except the water-insoluble globulin, from the refined prepa- 
rations one does not also exclude factors which may play an important 
part in overcoming the infection.  Experiments thus far show that as 
regards the non-antibacterial factor, although it is associated with the 
water-insoluble  globulin,  it  is  also  associated,  and  apparently  to 
the same degree, with the water-soluble globulin and probably with 
the albumen as well. 
It  thus  appeared  desirable  to  reinvestigate  the  fractionation  of 
antipneumococcic horse serum,  determining the therapeutic value of 
the  various  fractions  by  testing  against  the  experimental  dermal 
pneumococcus infection of rabbits.  From a  practical  point of view 
the immediate question  was  whether or not  a  concentrated, refined 
preparation, containing the  water-insoluble globulin only, was thera- 
peutically as  efficacious as  potent whole serum.  In a  comparison of 
such a preparation with an unrefined serum of approximately similar 
mouse protective potency, the former appeared to be not only as good 
but  even  better  than  the  latter.  It  thus  appears  that  the  water- 
insoluble globulin may contain all  the factors of the unrefined serum, 
in so far at least as one may judge  from  their  effects on the dermal 
infection of rabbits; the result, furthermore, is not as paradoxical as it 
may seem when one considers the possibility that different sera may 
vary  in  their  content  of  non-antibacterial  factor.  However,  to 
determine what loss,  if any, results from the exclusion of the water- 
soluble globulin, the 30 per cent (NH4)2SO4  globulin, and the albumen, 
from refined serum preparations, it is necessary to study the effect of 
the various fractions separately and to compare them with the original, 
unrefined serum from which they were derived.  Such a  study was 
undertaken with Serum 348,  a monovalent Type I  serum, containing 
at least 2,000  to 3,000  mouse protective units per cc. ALBERT  B.  SABIN  153 
The serum was fractionated in three different ways:  (1)  Standard fractionation 
with  (NH4)~SO4.  (2)  Preliminary dialysis and removal of acid fraction (Banzhaf- 
Klein technique (8)), with subsequent precipitation by (NH4)2SO4.  (3)  Prelimi- 
nary removal of acid fraction as in (2) and subsequent precipitation with sodium- 
magnesium sulfate. 
1.  Standard  Fractionation with (NH4)~SO4.--(a)  One portion of Serum 348 was 
precipitated by 50 per cent saturation with (NI-~SO4.  From half of the resulting 
total globulin, after dialysis, the total water-insoluble globulin was  obtained by 
dilution with distilled water.  (b)  Another portion of Serum 348 was precipitated 
by 30 per cent saturation with (NH4)2SO4; to the filtrate sufficient (NH4)~SO4 was 
added to increase the saturation to  50  per cent  (30  ~  50 per cent  (NH4)~SO4 
globulin).  Mter dialysis, these globulin fractions were dissolved in the  same vol- 
ume of 1 per cent NaC1 as the volume of serum from which they were  derived. 
From half the 30 ~  50 per cent (NH4)~SO4 globulin, the water-insoluble fraction was 
obtained by dilution with fifteen volumes of distilled water; after centrifugation 
the supernatant liquid was poured off and precipitated by 50 per cent saturation 
with (NH4)~SO4, the precipitate containing the water-soluble globulin. 
2.  Preliminary  Removal  of  Acid  Fraction;  Subsequent  Fractionation  with 
(Ntt4)zSO4.--The  acid fraction has already been referred to as that globulin frac- 
tion, which is insoluble at pH 5.0 and a  N/20 salt concentration, and which has 
been found to have associated  with it most of the chill-producing  principle,  when that 
principle is present in the original serum.  In the Banzhaf-Klein technique this 
fraction is removed by dialysis of the Original serum against running water for 3 
to 4 days, and by adjusting the dialyzed solution to a  salt concentration of N/20 
and a  pH 5.0.  After thus removing the acid fraction from a  quantity of Serum 
348, we did not follow their technique further; the remaining solution was divided 
in two lots.  One lot was then precipitated with (NH4)2SO4 as in Paragraph 1 (a) ; 
the other was saved for Experiment 3. 
3.  Fractionation  with  47.5  Per  Cent  Sodium-Magnesium  Sulfate.--For  the 
fractionation of antityphoid serum, Reiner and Shwartzman (9) used 47.5 per cent 
sodium-magnesium sulfate as the equivalent of saturated  (NH4)2SO4 and  found 
the antibody, that they were studying, in what corresponds to the fraction obtained 
with  30  ~  50  per cent  (NH4)2SO4 saturation.  They  preferred the use  of  the 
sodium-magnesium sulfate to that of (NH4)2SO4, because of ease with which nitro- 
gen determinations could be made, and employed it instead of Na2SO4, because it 
could be used at room temperature. 
To the lot of serum saved as described in Paragraph 2,  sufficient of the 47.5 
per cent sodium-magnesium sulfate solution was added for a  final concentration 
of 14 per cent of the salt by weight, which should correspond approximately to 30 
per cent saturation with  (NH4),SO4.  To  the filtrate more of the  sodium-mag- 
nesium sulfate was  added to increase its concentration to 24 per cent,  or what 
should correspond to 50 per cent saturation with (NH4)2SO4. 154  ACTION  OF  ANTIPNEUMOCOCCIC  SERUM.  II 
The volumes of all fractions are comparable with that of the original 
serum.  As a  rule, five rabbits were used for each dose.  In several 
instances when the outcome appeared doubtful the test was repeated. 
The  same  procedure,  previously  outlined  for  the  rabbit  test,  was 
followed.  On account of the large volume of data, Table III indicates 
only the survival or death of the rabbits used. 
Original Serum 348.--The original serum proved to be effective in 
a  dose as low as 0.075  cc.  With this dose, although all  the dermal 
lesions were very severe, three of the five rabbits survived with a drop 
in  temperature by crisis between the 2nd  and 4th days and  rather 
slow resolution of the lesions.  In the rabbits that died the tempera- 
ture remained high until the end, one dying with, and the other without 
a  bacteremia.  Excepting the death of an occasional rabbit, with a 
resistance apparently lower than that  of the average,  there was no 
indication of a zone phenomenon in the higher doses. 
50 Per Cent (NH4)2S04 Globulin.--This fraction represents the total 
globulin of the serum.  Paradoxical as it may seem, this fraction, in 
equivalent volume, in spite of a  certain unavoidable loss incurred by 
the necessary manipulations of the process, actually proved to be more 
potent than  the original.  Although an end-point was not reached, 
the lowest dose tested, 0.05  cc., gave the same result as 0.075  cc. of 
the original serum.  With 0.075  cc. of the total globulin, the rabbits 
responded decidedly better than with the same dose of the original 
serum, the dermal lesions being very slight and the temperatures drop- 
ping to normal within 1 day. 
50  Per Cent  (NH4)~SO, Globulin: Water-Insoluble  Fraction.--This 
fraction  represents  the  entire  water-insoluble  globulin  and  differs 
from the total globulin, just described, by the exclusion of the total 
water-soluble portion.  It is interesting to note that the water-insolu- 
ble  globulin  alone  appears  to  be  as  potent  as  the  original  serum, 
although when compared with the total globulin it is decidedly less 
effective both quantitatively and qualitatively, the lesion and tempera- 
ture being much better controlled with the latter. 
30 -* 50 Per Cent (NH4)~S04 Globulin: TotaL--The purpose of test- 
ing this fraction was to determine the effect of excluding the globulin, 
which  is  precipitated  by  30  per  cent  saturation  with  (NH,),SO4. 
The potency of this fraction is definitely less than either the original ALBERT  B.  SABIN  155 
serum or the  total  globulin,  its M.E.D. probably being about 0.1  cc. 
A  peculiar  zone phenomenon presented  itself.  In  the first test,  the 
0.2  and 0.15 cc. doses were definitely ineffective, whereas the 0.1  cc. 
dose was fully effective; not only did fewer rabbits survive with those 
doses, but the dermal lesions and the course of the disease were con- 
siderably worse.  The  test was repeated  with 0.3  and  0.1  cc.  The 
rabbits  receiving the higher  dose were again  definitely worse.  This 
fraction  was then  isolated  from  another  portion  of Serum  348,  and 
after pressing  and  absorbing  away most of the  excess  (NH,)2SO4, it 
was dissolved by the remaining imbibed salt and the addition of dis- 
tilled water, instead of by 1 per cent NaC1 after dialysis of the (NH4)~- 
SO4.  Tests performed with 0.2 and 0.1 cc., showed the former to 1)e 
the M.E.D. ; no zone phenomenon was now observed. 
30--~ 50 Per Cent (NH4)2S04 Globulin: (a) Water-Insoluble Fraction.-- 
This fraction excludes both the 30 per cent (NH,),SO4 globulin and the 
water-soluble portion  of the  30  --~ 50  per  cent  (NI~),SO4  globulin. 
It  is  the  globulin  which  constitutes  the  refined  preparations  made 
according  to  Banzhaf's  technique.  The  results  of  the  rabbit  tests 
obtained with this  water-insoluble fraction  are almost identical  with 
those of the  total  30  --~ 50 per  cent  (NH,)2SO, globulin;  it  has  the 
same m.E.D, and  the  same zone phenomenon. 
This zone phenomenon  apparently  differs from the prozone some- 
times  observed  in  agglutination  and  other  immunological,  in  vitro, 
reactions, as well as in the mouse protection test, in that the effective 
zone is so narrowly limited.  Another peculiarity requiring  explana- 
tion is the fact that  the  original  serum,  the  total  globulin, and  the 
total water-insoluble globulin  did not  exhibit this phenomenon in the 
same range of dosage; it appears as though the removal of the 30 per 
cent (NH4)~SO4 fraction had upset some equilibrium which prevented 
this zone phenomenon.  An examination of the results obtained with 
the 30 --. 50 per cent (NI-I4)2SO4 fraction of Serum  54  (see Table II) 
suggests the operation of a  similar phenomenon there,  for the lesions 
and course of the rabbits treated with 0.6 cc. were definitely worse than 
in those treated with 0.2  cc.  It cannot be stated how common this 
zone phenomenon may be, but it is obvious that  at least in  this in- 
stance,  the  30  --*  50  per  cent  (NH4)2SO4  globulin,  either  total or 
water-insoluble, would be quite undesirable for therapeutic purposes. "Po 
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It is interesting  to note that  agglutination  tests with  the  fraction of 
Serum 348 (Table IV), all performed at the same time with the same 
antigen, showed neither a zone phenomenon, nor any parallelism with 
the  therapeutic  results obtained  on  the  rabbits.  The  agglutination 
tests were better  correlated  with  the  mouse protection  tests,  which 
also  showed no  zone i~henomenon;  in  the  mouse protection  test,  as 
contrasted with the results obtained in the rabbits, the 30 --~ 50 per 
cent (NH,)2SO4 globulin was more potent than the total globulin. 
TABLE  IV 
Agglutination Test with Protein Fractions of Serum 348 
Preparation 
Original Serum 348 ......... 
50  per  cent  (NI-I,)2SO,  glob- 
ulin; total ............... 
50  per  cent  (NI-I,),SO4  glob- 
ulin; water-insoluble ...... 
30  --~ 50 per cent  (NH4),SO4 
globulin; total ............ 
30  --+ SO per cent  (NI-I,)2SO4 
globulin;  water-insoluble.. 
30  --* S0 per  cent  (NH4)2SO4 
globulin; water-soluble .... 
30 per cent (NI~)2SO4 globulin. 
Un- 
diluted 
++++ 
++++ 
++++ 
++++ 
Dilution of preparation  before addition of antigen 
1:2  I:S 
--Z-++ 
:++++ 
+++ 
++++ 
++++ 
++ 
1:I0  i  1:20 
++++i +++ 
-H-++  ++-t 
++++  +q-4 
++++  +++ 
+++-t- ' +++ 
_  _  ]  - 
±  i  - 
÷+t':40  ____~1:80] 
-++  +  - 
1:100 
-1- + + q-  =  complete agglutination.  +  =  very slight agglutination.  -4-  = 
doubtful agglutination. 
30 --~ 50 Per Cent (Ntt,)~SO, Globulin: (b)  Water-Soluble Fraction.- 
It is important  to observe that  this fraction,  which is not  the total 
water-soluble globulin,  and which has very little of the antibacterial 
bodies associated with it, contains approximately 10 to 15 per cent of 
the potency of the original serum.  It is also essential to recall that in 
the  processes of refining  and  concentrating  serum  at present in use, 
this  fraction  would be  discarded,  although  it  is,  by itself,  quite  as 
efficacious as some sera which would be considered good, and suitable 
for therapeutic purposes (see Serum 54, Table II). 160  ACTION  OF  ANTIPNEUMOCOCCIC  SERUM.  II 
30 Per Cent (NH,)2S04 Globulin.--Although  an  end-point  was not 
reached in the test on this fraction, it is apparent that at least 25 per 
cent of the potency of the original serum is associated with it. 
Removal of Acid Fraction from  Whole Serum, Preliminary to Salt 
Fractionation.--Since the removal of the acid fraction is desirable in 
certain instances,  it was essential to observe tile effect which various 
ways of eliminating  it might  have on the final  preparation.  In  the 
preceding  experiment  (Table II)  it was  removed  from  the 30 ~  50 
per  cent  (NH4)2SO,  globulin  of  Serum  54;  but  since  this  globulii~ 
fraction has proved  to be less desirable for therapeutic purposes than 
the total globulin, the effect of eliminating the acid fraction from the 
latter had  to be tested.  Using the  Banzhaf-Klein  technique,  it was 
eliminated  from Serum 348.  The  amount of acid  fraction  that  was 
precipitated  was  rather  small;  part  of  the  remaining  protein  was 
fractionated  with  (NH4),SO4  and  part  with  sodium-magnesium 
sulfate. 
50 Per Cent (NH4)~S04 Globulin.--The M.E.D. appears to be as much 
as 0.3 cc. as compared with a  M.E.D. of at least 0.05 cc. for the total 
globulin, isolated from the same serum which was not subjected to this 
preliminary  process. 
50 Per Cent (NH4)~S04; Water-Insoluble Fraction.--This fraction was 
derived from the preceding one by dilution  with distilled water;  the 
total  water-soluble  globulin  is  thus  excluded.  No  end-point  was 
reached in this test, but a  seeming paradox is again evident here,  in 
that the part appears to be more effective than the whole.  The rab- 
bits treated with the higher doses appear to have had a worse course 
and fewer survived. 
It is difficult to account for the marked  reduction  in the potency 
and effectiveness of the fractions obtained with  (NI-I4)~SO4 simply by 
the removal of the  small amount  of acid precipitate;  it  seems more 
likely that  the prolonged dialysis to which the  serum was subjected 
prior  to  the  fractionation  with  (NtL)zSO,,  had  somehow influenced 
the subsequent precipitation of the antibody. 
14  Per  Cent Sodium-Magnesium Sulfate  Globutin.--This  fraction 
which should have corresponded to the 30 per cent (NH,)2SO4 globulin, 
proved to be considerably more potent.  The zone phenomenon was 
strikingly evident in this test; all the rabbits treated with 0.6 cc. died, ALBERT  B.  SABIN  161 
whereas 0.15 cc. was an effective dose.  This fraction had 4.5 rag. of 
nitrogen per cc., and almost all the agglutinins were associated with it. 
14  --~  24  Per  Cent  Sodium-Magnesium  Sulfate  Globulin.--This 
fraction,  which  should  have  corresponded to  the  30  --~  50 per  cent 
(NH4),.SO, globulin, had 3.0 rag. of nitrogen per cc. and was ineffective 
in the three doses tested. 
Whether  or not  it  be the  effect of the  preliminary dialysis of the 
serum, the 47.5 per cent sodium-magnesium sulfate solution certainly 
did not behave like the equivalent of saturated (NH4)~SO4 with regard 
to the antibodies in antipneumococcic serum. 
DISCUSSION  AND  SUMMARy 
The experiments of the preceding communication  showed that the 
therapeutic action of antipneumococcic serum depends to a considera- 
ble extent upon a  certain non-antibacterial  factor.  The experiments 
reported  in  the  present  communication  had  two  main  objects;  the 
first was to determine the distribution of the non-antibacterial factor 
among the various protein fractions of the serum, and incidentally to 
correlate this property of the factor with that of certain known anti- 
bodies, as well as to learn  whether  or not the protein fractions com- 
monly excluded from refined preparations of antipneumococcic serum, 
have  any  therapeutic  value;  the  second  was  to  determine  the  r61e 
of the non-antibacterial  factor in the therapy of pneumococcus infec- 
tion,  as  exemplified  by  the  experimental,  dermal,  pneumococcus 
infection  in  rabbits. 
To determine the distribution of the non-antibacterial factor, Type 
I  antipneumococcic serum was fractionated with  (NH~)~SO4, and the 
antibacterial  bodies were  absorbed  by  concentrated  suspensions  of 
heat-killed  pneumococci.  The  activity  of  the  non-antibacterial 
factor in the different protein fractions was then tested for by adding 
varying  amounts  of  the  absorbed  supernatant  liquids  to  a  certain 
constant,  subeffective dose  of  serum.  Even  though  the  method  of 
titration  has certain  inherent  faults it was possible to ascertain  that 
the  non-antibacterial  factor  was  apparently  associated  with  all  the 
globulin fractions to a similar degree, and to a certain extent with the 
albumen as well.  In this respect the non-antibacterial  factor resem- 162  ACTION  OF  ANTIPNEU•OCOCCIC  SERUM.  II 
bles neither the antibacterial bodies of antipneumococcic serum, nor, 
for example, the known diphtheria or tetanus antitoxins. 
The determination of the relative importance of the antibacterial and 
non-antibacterial factors in the therapy of pneumococcus infection in 
rabbits,  was rendered possible  by the fact that  the various globulin 
fractions  differ in  their  relative  content  of  the  two factors.  Thus 
whereas the water-insoluble fraction of the globulin, precipitated when 
the saturation of (NH4)~SO4 is raised from 30 per cent to 50 per cent, 
contains  about  90  per  cent of the  antibacterial  (mouse protective) 
bodies, it apparently contains no more of the non-antibacterial factor 
than the water-soluble fraction.  The minimal effective doses as well 
as the mouse protective unit content of the different fractions were 
determined.  Before the tests were performed, it seemed that if the 
therapeutic effect of a given dose were to depend chiefly upon its con- 
tent of mouse protective antibody, the amounts required for 1 M.E.D. 
would  be  determined by  the  number of mouse  protective  units  it 
contained; on the other hand, if it depended primarily on the non- 
antibacterial  factor,  one  would  expect  the amounts required for  1 
M.E.D. to be of approximately the same volume.  Actually the thera- 
peutic  effect was  found  not  to  depend  entirely upon either factor, 
alone; the M.E.D.'s varied  both  in  volume  and  m.p.u,  content,  the 
absolute concentration of either factor being inconstant and almost 
proportional to the relative concentration of the other.  Thus a rela- 
tive abundance of non-antibacterial factor made up for a scarcity of 
mouse protective  antibody  (as  in  the  water-soluble  globulin),  and 
vice versa  (as in the water-insoluble globulin).  It appears, therefore, 
that when a relatively larger amount of antibacterial bodies are acting, 
less of the non-antibacterial factor is necessary; conversely, when more 
of the  non-antibacterial  factor is  available, less of the antibacterial 
bodies are necessary. 
The last experiment dealt with the practical question as to whether 
any protein fraction or combination of fractions is as good a therapeu- 
tic agent as the whole, unrefined serum from which it was derived. 
Two considerations were in mind in making the comparison; one had 
to do with the quantitative recovery of potency, the other with the 
qualitative effect of the various fractions as regards the lesion, course, 
and duration of the experimental disease.  The results may be sum- ALBERT B.  SABIN  163 
marized as follows:  (a) the total globulin was not only as good, but in 
this instance, definitely better than the original serum; (b)  the total 
water-insoluble  globulin,  although  almost  as potent  as the original 
serum, was qualitatively and quantitatively less effective than the total 
globulin;  (c)  the removal of the 30 per cent (NH4)2504  fraction not 
only diminished the potency of the remaining globulin to a considerable 
extent (at least 25 per cent), but also seems to have disturbed a certain 
equilibrium, which resulted in an undesirable zone phenomenon.  As 
a result of this zone phenomenon, which, it is important to note, was 
not observed in  the agglutination or mouse protection  tests  on the 
same fractions, the range of effective dosage is very narrowly limited. 
Although the results of agglutination tests correlated well with those 
of the mouse protection  tests,  both  of these showed no  parallelism 
with  the  therapeutic  effects of  the various  fractions on  the experi- 
mental, dermal, pneumococcus infection in rabbits. 
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